Tactogen

Developing new MDMA-like medicines for effective prescription mental wellness
Overview
Raised: $94,542
Total Commitments ($USD)
Wefunder
11/11/2022
01/31/2023
$50,000
$5,000,000
$100
SAFE
Seed
RegCF
$80,000,000
15%
Rolling Commitments ($USD)
02/01/2023
189%
2%
$1,167
165
Palo Alto, California
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Medium
High
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-2,483,543 |
$-428,556 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$1,784,371 |
$733,443 |
Accounts Receivable |
$8,958 |
$0 |
Total Assets |
$1,799,821 |
$743,111 |
Short-Term Debt |
$136,981 |
$55,689 |
Long-Term Debt |
$0 |
$0 |
Total Liabilities |
$136,981 |
$55,689 |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual